Adjunctive Pentoxifylline Enhances Clinical Remission and Reduces Inflammatory Biomarkers in Mild-to-Moderate Ulcerative Colitis: A Randomized Double-Blind Placebo-Controlled Pilot Trial.

Saved in:
Bibliographic Details
Title: Adjunctive Pentoxifylline Enhances Clinical Remission and Reduces Inflammatory Biomarkers in Mild-to-Moderate Ulcerative Colitis: A Randomized Double-Blind Placebo-Controlled Pilot Trial.
Authors: Khrieba, Mohannad O.1,2 (AUTHOR), Abdulelah, Furqan M.2,3 (AUTHOR), Badawoud, Amal Mohammed3,4 (AUTHOR) ambadawoud@pnu.edu.sa, Hamza, Eman4,5 (AUTHOR), Al-Dhelaan, Reham A.5 (AUTHOR), Ahmed, Tarek I.6 (AUTHOR), Abdelhameed, Ahmed G.7,8 (AUTHOR), Elshorbagi, Nora8,9 (AUTHOR), El-Hanafy, Doaa A.9,10 (AUTHOR), Eltantawy, Nashwa10,11 (AUTHOR), Salahuddin, Muhammed M.8,11 (AUTHOR), Elkhodary, Noha M.12 (AUTHOR), Radwan, Kholoud H.13 (AUTHOR), Khalaf Ali, Khaled Abo Bakr14 (AUTHOR), El-Sayed, Abeer A.15 (AUTHOR), Kamal, Marwa16 (AUTHOR)
Source: Pharmaceuticals (14248247). Apr2026, Vol. 19 Issue 4, p552. 25p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14248247
DOI:10.3390/ph19040552